The Netherlands
iClusion
Slogan: Access to clinical trials: Serving professionals with the Trial-Eye infrastructure and patients with Heyleys
Description: iClusion aims to increase cancer patient participation in clinical trials from 5% to 25%. Through their Professional Service 'Trial Eye' (www.trial-eye.com), they streamline patient recruitment, connect oncologists, sponsors, and sites, and implement study start-up procedures compliant with regulatory requirements. Additionally, their Public Service 'Heyleys' (www.heyleys.nl) provides information on recruiting oncology trials for the general public in the Netherlands, aiding patients in discussing treatment options with their oncologists.
Founded: 2015
Industries: Care Economy, Health Care
Headquarter: Information not available
Last Investment: Information not available
Last Investment Investors: Information not available
As of now, iClusion remains an intriguing prospect in the healthcare industry as it endeavors to address the disparity between patient interest in clinical trials and their actual participation rates. With an innovative approach through Trial Eye and Heyleys, the startup seeks to make clinical trials more accessible and comprehensible for both professionals and patients. Despite the absence of information regarding the last investment and investors, iClusion's focus on addressing critical healthcare challenges renders it a compelling contender for potential investment and strategic partnerships.
